U.S. flag

An official website of the United States government

esv18933

  • Variant Calls:3
  • Validation:Yes
  • Clinical Assertions: No
  • Region Size:168,263

Links to Other Resources

Source: NCBI

Genome View

Select assembly:
Overlapping variant regions from other studies: 1147 SVs from 87 studies. See in: genome view    
Remapped(Score: Perfect):130,044,909-130,213,171Question Mark
Overlapping variant regions from other studies: 1147 SVs from 87 studies. See in: genome view    
Remapped(Score: Perfect):129,763,752-129,932,014Question Mark
Overlapping variant regions from other studies: 652 SVs from 29 studies. See in: genome view    
Submitted genomic131,246,442-131,414,704Question Mark

Variant Region Placement Information

Variant Region IDPlacement TypeScoreAssemblyAssembly UnitReciprocitySequence IDChrInner StartInner Stop
esv18933RemappedPerfectGRCh38.p12Primary AssemblyFirst PassNC_000003.12Chr3130,044,909130,213,171
esv18933RemappedPerfectGRCh37.p13Primary AssemblyFirst PassNC_000003.11Chr3129,763,752129,932,014
esv18933Submitted genomicNCBI36 (hg18)Primary AssemblyNC_000003.10Chr3131,246,442131,414,704

Variant Call Information

Variant Call IDTypeSample IDMethodAnalysisOther Calls in this Sample and Study
essv35045copy number gainNA18502Oligo aCGHProbe signal intensity1,373
essv35893copy number gainNA18907Oligo aCGHProbe signal intensity1,412
essv68023copy number gainNA18858Oligo aCGHProbe signal intensity1,507

Variant Call Placement Information

Variant Call IDPlacement TypeScoreHGVSAssemblyReciprocitySequence IDChrInner StartInner Stop
essv35045RemappedPerfectNC_000003.12:g.(?_
130044909)_(130190
360_?)dup
GRCh38.p12First PassNC_000003.12Chr3130,044,909130,190,360
essv35893RemappedPerfectNC_000003.12:g.(?_
130045029)_(130204
193_?)dup
GRCh38.p12First PassNC_000003.12Chr3130,045,029130,204,193
essv68023RemappedPerfectNC_000003.12:g.(?_
130045029)_(130213
171_?)dup
GRCh38.p12First PassNC_000003.12Chr3130,045,029130,213,171
essv35045RemappedPerfectNC_000003.11:g.(?_
129763752)_(129909
203_?)dup
GRCh37.p13First PassNC_000003.11Chr3129,763,752129,909,203
essv35893RemappedPerfectNC_000003.11:g.(?_
129763872)_(129923
036_?)dup
GRCh37.p13First PassNC_000003.11Chr3129,763,872129,923,036
essv68023RemappedPerfectNC_000003.11:g.(?_
129763872)_(129932
014_?)dup
GRCh37.p13First PassNC_000003.11Chr3129,763,872129,932,014
essv35045Submitted genomicNC_000003.10:g.(?_
131246442)_(131391
893_?)dup
NCBI36 (hg18)NC_000003.10Chr3131,246,442131,391,893
essv35893Submitted genomicNC_000003.10:g.(?_
131246562)_(131405
726_?)dup
NCBI36 (hg18)NC_000003.10Chr3131,246,562131,405,726
essv68023Submitted genomicNC_000003.10:g.(?_
131246562)_(131414
704_?)dup
NCBI36 (hg18)NC_000003.10Chr3131,246,562131,414,704

Validation Information

Variant Call IDExperiment IDSample IDMethodAnalysisResult
essv350452NA18502Oligo aCGHProbe signal intensityPass
essv680232NA18858Oligo aCGHProbe signal intensityPass
essv358932NA18907Oligo aCGHProbe signal intensityPass

No clinical assertion data were submitted for this variant

No genotype data were submitted for this variant

Support Center